Senores Pharmaceuticals Limited has informed the Exchange about appointment of Secretarial Auditor for a period of five (5) consecutive years from FY 2025‐26 to FY 2029‐30
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has appointed M/s. Mukesh H. Shah & Co., Company Secretaries in Practice, as its Secretarial Auditor for a five-year term covering FY 2025-26 to FY 2029-30. The Board approved the appointment on May 15, 2025, on the recommendation of the Audit Committee, and it is subject to shareholder approval at the next general meeting. The appointed firm is a peer-reviewed practicing company secretarial outfit with over two decades of experience working with listed and closely-held companies. The disclosure is filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory compliance disclosure with no material impact on shareholders or the stock price. It does not involve any change in key managerial personnel, financial auditors, or board composition.